IMCD NV【IMCD】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

137.30

買値

137.20

売値

137.35

出来高

7,454

136.85 日の範囲 138.05

126.65 52 週間の範囲 169.05

時価総額

7.824B

前日終値

138.00

始値

138.05

時刻

137.3

最終取引時間

19:20:30

財務取引量

VWAP

平均取引量 (3 か月)

88,305

発行済株式数

56,988,000

配当利回り

PER

26.81

1 株当たり利益 (EPS)

5.13

歳入

4.47B

純利益

292.27M

セクター

Chemicals & Chem Preps, Nec

業界

Chemicals & Chem Preps, Nec

ウェブサイト

www.imcdgroup.com

本社

Rotterdam, South Holland, Nld

設立

IMCD NV is listed in the Chemicals & Chem Preps sector of the ユーロネクスト with ticker IMCD. The last closing price for IMCD NV was 138.00 €. Over the last year, IMCD NV shares have traded in a share price range of 126.65 € to 169.05 €.

IMCD NV currently has 56,988,000 shares in issue. The market capitalisation of IMCD NV is 7.86 € billion. IMCD NV has a price to earnings ratio (PE ratio) of 26.81.

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART...

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE...

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD reports EBITA of EUR 403 million in the first nine months of 2024 Rotterdam, The Netherlands (8 November 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and...

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America ROTTERDAM, The Netherlands (17 October 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading...

IMCD successfully issues a EUR 500 million rated bond

IMCD successfully issues a EUR 500 million rated bond ROTTERDAM, The Netherlands (29 August 2024, 17:45 hrs CEST) – IMCD N.V. (“IMCD”) a leading distributor of speciality chemicals and food...

IMCD reports EBITA of EUR 270 million in the first half of 2024

IMCD reports EBITA of EUR 270 million in the first half of 2024 Rotterdam, The Netherlands (2 August 2024) - IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, and formulator...

IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica

IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of...

Shareholders IMCD N.V. adopt all resolutions at AGM

Shareholders IMCD N.V. adopt all resolutions at AGM ROTTERDAM, The Netherlands (14 May 2024, 17:00 hrs CEST) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner...

IMCD reports EBITA of EUR 127 million in the first three months of 2024

IMCD reports EBITA of EUR 127 million in the first three months of 2024 Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner...

IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma

IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of...